Search results
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoAustin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market Size, Trends and ...
Regeneron (REGN) Announces Positive Data on Oncology Candidate
Zacks via Yahoo Finance· 1 day agoRegeneron's (REGN) REGN7075, in combination with its oncology drug Libtayo, generates anti-tumor...
Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of...
Digital Journal· 2 days agoStages 1 and 2 cSCC represent 77% of all new cSCC annually. There are no drug products approved for treatment of Stages 1 and 2 cSCC. "We are pleased to share our progress ...
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
Forbes· 6 days agoIn 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 3 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
The Current State Of Skin Cancer
Women s Health· 2 days agoThe American Academy of Dermatology also points out that the rates of melanoma in people under 50 are higher in women than in men. “The incidence of...
OncoHost to Present Poster Demonstrating PROphet®'s Application in Multiple Cancer Indications at...
FOX21 Colorado Springs· 2 days agoOncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced that it has been accepted for a poster presentation at the upcoming ...
Study Finds Radiotherapy for NMSC in Dermatology Growing
Medscape· 5 days agoThe use of radiotherapy has been steadily increasing by dermatologists, according to new findings...
Chemoradiotherapy or RT in Lower Risk Early Cervical Cancer?
Medscape· 4 days agoA study found no significant differences in survival with postoperative chemoradiotherapy vs RT...
ASCO: Early peek at Merus' bispecific cancer data lives up to investors' expectations
FierceBiotech· 1 day agoAnalysts have hailed Merus’ latest data drop in head and neck cancer as meeting investors’...